Home
Search
Subscribe
Henry M. Jackson Foundation for the Advancement of Military Medicine
Advancing Military Medicine
Search Results - ovarian+cancer
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Diagnostic Tool for High-grade Serous
Ovarian Cancer
- (HJF 616-21)
Researchers at HJF, Inova Fairfax Hospital (IFH), and the Peter MacCallum Cancer Center (PMCC) have identified orthogonal protein and transcript-based biomarkers correlating with Homologous Recombination Deficiency (HRD). This may lead to a companion clinical diagnostic assay to prioritize High-Grade Serous
Ovarian Cancer
(HGSOC) patients for targeted...
Published: 12/12/2024
|
Updated: 12/12/2024
|
Inventor(s):
Nicholas Bateman
,
Tamara Abulez
,
Thomas Conrads
,
George Larry Maxwell
,
Dale Garsed
,
David Bowtell
,
Ahwan Pandey
Keywords(s):
Assay
,
Biomarker Assay
,
Companion Diagnostic
,
DDR
,
DNA Damage Repair
,
HGSOC
,
High-Grade Serous Ovarian Carcinoma
,
Ovarian Cancer
,
PARP Inhibitors
Category(s):
Diagnostics
,
Therapeutic
Peptide Vaccine for Preventing Recurrence of Ovarian or Endometrial Cancer - (HJF 593-21, HJF 592-21)
Preventing cancer recurrence remains an unmet clinical need. A cancer peptide vaccine technology, available from HJF for licensing, has shown significant clinical efficacy in preventing and reducing the risk of recurrence of ovarian and endometrial cancers. Applications and Advantages Significant clinical efficacy demonstrated in human studies Personalized...
Published: 5/6/2024
|
Updated: 5/19/2022
|
Inventor(s):
George Peoples
Keywords(s):
Cancer Vaccine
,
Endometrial Cancer
,
Oncology
,
Ovarian Cancer
,
Therapeutics
Category(s):
Therapeutic